Circulation, Vol 54, 591-598, Copyright © 1976 by American Heart Association
LD Hillis, J Askenazi, E Braunwald, P Radvany, JE Muller, MC Fishbein and PR Maroko
The goal of this study was to determine if changes in the epicardial QRS
complex after coronary artery occlusion (CAO) can be used to evaluate the
efficacy of interventions designed to limit infarct size. Forty-one
open-chest dogs with CAO were studied: 15 were controls, 18 received
hyaluronidase and eight received propranolol starting 20 minutes after CAO.
Epicardial ECGs were recorded at specific time intervals to analyze
ST-segment elevation and changes in Q and R waves. Transmural specimens
were obtained 24 hours after CAO from the same sites at which ECGs were
recorded. Q wave development (deltaQ), R wave fall (deltaR), and their
combination (deltaR + deltaQ) at 24 hours correlated with the extent of
necrosis, as determined by myocardial creatine phosphokinase activity
depression and histologic appearance. In the control group ST-segment
elevation 15 minutes after CAO (ST15M) predicted changes in Q and R waves
24 hours later; in the treated groups, the same ST15M prior to drug
administration resulted in significantly less QRS changes. Thus, 1) Q wave
development and R wave fall 24 hours after CAO accurately reflect
myocardial necrosis. 2) ST15M predicts subsequent changes in Q and R waves.
3) The efficacy of hyaluronidase and propranolol, agents previously shown
to reduce myocardial necrosis, can be detected by less Q wave development
and a smaller fall in R wave voltage.
ARTICLES
Use of changes in the epicardial QRS complex to assess interventions which modify the extent of myocardial necrosis following coronary artery occlusion
This article has been cited by other articles:
![]() |
D. C. Babalis, G. N. Boutos, E. K. Iliodromitis, A. K. Trovas, and E. M. Vorides Precordial ECG Mapping in Acute Myocardial Infarction (AMI) After Intravenous Infusion of Streptokinase (s) Angiology, December 1, 1989; 40(12): 1040 - 1047. [Abstract] [PDF] |
||||
![]() |
F. A. Cecena-Seldner and J. Villarreal Effect of the Kallikrein Inhibitor Aprotinin on Myocardial Ischemia and Necrosis in Man Angiology, July 1, 1980; 31(7): 488 - 496. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1976 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |